The PennZone

  • Home
  • Business
  • Construction
  • Health
  • Real Estate
  • Technology
  • Non-profit
  • Entertainment
  • Education

Nattokinase Supplement for Cardiovascular and Circulatory Support
The PennZone/10270754

Trending...
  • Why We're Holding the Line on Pricing
  • Shoutout Joseph Neibich aka Nybyk
  • Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
Nattokinase Heart Health Supplement
AgeImmune's Nattokinase is one of the purest professional grade supplement on the market which is beneficial for overall heart health.

NEW YORK - PennZone -- Dr. Kanevsky, D.C. C.F.M.P. introduced a new supplement to AgeImmune's product line
earlier this May 2024.
A new addition to the family is Nattokinase supplement in a form of a vegetable capsule
each containing 2,000FU (fibrin unit) representing a unit of potency, which is equal to
100mg. Dr. Kanevsky is recommending a serving size of 2 capsules. However, if you
are in excellent heart health with no family history of blood clots, 1 capsule is enough as
a preventative measure.
Nattokinase is an enzyme derived from Japanese soybean called Natto via fermentation
process with a bacteria called Bacillus subtilis. Natto has been consumed as a
traditional food in Asia for over 2000 years and is believed to be a significant contributor

More on The PennZone
  • GDE Tree Services Expands Operations into Sydney, NSW
  • Tuckwell Machinery Expands CNC Range to Support Australian Cabinet Makers
  • The Inner Power of Emotional Self-Leadership
  • Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
  • Best Companies Group Opens Free Registration for Best Places to Work in Insurance Program

to the longevity of the Japanese people. Although natto has been consumed in Asia for
thousands of years, the fibrinolytic and antithrombolytic property of Nattokinasae was
only discovered in 1987. Recent studies demonstrated that high natto intake is
associated with decreased risk of cardiovascular disease.
This was a sufficient reason for Dr. Kanevsky to add Nattokinase to his line of products.
There is some early evidence that nattokinase may thin the blood and help break up
blood clots. This might protect against heart disease and conditions caused by blood
clots such as stroke, heart attack, and others.
Other studies show that nattokinase may help lower blood pressure and reduce
inflammation in the body.
Unlike traditional blood thinning medications, nattokinase is a natural, widely available
and inexpensive supplement with minimal to no side effects which makes is very

More on The PennZone
  • Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
  • Epic Pictures Group Sets North American Release Date for the Thriller NO ORDINARY HEIST
  • Mobile Copywriter Celebrates 13 Years of Content Creation and SEO Services
  • Award-Winning REALTORĀ® Paige Coker Joins Corcoran DeRonja Real Estate
  • Over 98% of crypto owners globally don't declare taxes, new report find

attractive to Dr. Kanevsky's patients searching for an all-natural approach to their
health.
Having a large database of functional medicine patients Dr Kanevsky easily analyzed
the frequency of complains of a poor heart health, circulation, blood pressure and came
to a conclusion that Nattokinase will become one of the most popular products for
AgeImmune.
As always encapsulated without harmful excipients such as magnesium stearate, silicon
dioxide or titanium dioxide, AgeImmune's Nattokinase is one of the purest professional
grade supplement on the market.
Nattokinase supplement is derived from soy. Dr. Kanevsky warns that if you are allergic
to soy, you shouldn't be taking Nattokinase. It is currently available for purchase at a
discounted price of 21.99 on AgeImmune's website and on Amazon

Contact
AgeImmine
***@netembark.com


Source: Nattokinase Heart Health Supplement

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • EFA Announces 2026 Editorial Rate Chart
  • Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
  • Shoutout Joseph Neibich aka Nybyk
  • Meet Joseph Neibich aka Joseph Nybyk of Beachwood Canyon
  • LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
  • KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
  • Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
  • Why We're Holding the Line on Pricing
  • Moravian Academy Announces New Full-Tuition Impact Scholarship for Upper School Students
  • AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
  • Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
  • National Focus Turns to Global Conflict, Families of Veterans Lost to Suicide Call for Recognition
  • New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
  • Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
  • Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
  • ATTAIN Profiles the Invisible Billionaire Who Started With $75 and Died the Richest Man in A
  • Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
  • NEW MANAGEMENT BOOK: Creating a Joy-Centric Culture
  • QuickTrack by Datalex Transforms Retail Promoter Management with Claude AI and Real-Time Insights
  • Kaltra Introduces Seasonal Discounts on Replacement Coils for Carrier, York, and Trane Chillers

Popular on PennZone

  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
  • Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
  • Hope Survives Launches The Hope Collective, A Curated Publication Centering Lived Experience After Brain Injury
  • Claude Riveloux Review 2026: How the $10B Fund Manager Dispels 'Scam' Rumors Through Education
  • Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
  • Conexwest: Shipping Containers Are Powering the Next Generation of Bitcoin Mining Infrastructure
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida

Similar on PennZone

  • SelfCare is now HealthCare across America
  • LiposoMoreā„¢ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • The Inner Power of Emotional Self-Leadership
  • Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
  • Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
  • Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
  • Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
  • Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
  • Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
  • QuickTrack by Datalex Transforms Retail Promoter Management with Claude AI and Real-Time Insights
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us